Lifevantage Corporation (LFVN) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Lifevantage Corporation stock $8.46, price $5.22, upside +62.1%, quality 67 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range $2.69 – $24.81 · fair‑value band $6.13 – $10.58 · the $5.22 price screens below the $8.46 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Lifevantage in your weekly email
Every Wednesday you see whether Lifevantage is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.
Show moreShow less
It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
Stock analysis
Lifevantage Corporation (LFVN) currently trades at $5.22, while our model-based Fair Value estimate is $8.46, implying the stock looks roughly 38% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $9.50 per share, and 17 of the 26 models we run sit above the $5.22 price.
Bear case: the Dividend Discount group reads lowest at $2.28, and 9 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: $6.13 (bear) to $10.58 (bull), the price of $5.22 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Consumer Defensive sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Lifevantage Corporation reported revenue of $183M in FY2026 versus $206M in FY2022, a compound −3.0%/yr. Reported net income was $5.1M in FY2026, compounding +12.9%/yr from FY2022.
Key figures
Market cap $66.2M Micro · P/E ratio 12.7 · P/S ratio 0.36 · EPS (TTM) $0.4100 · Dividend yield 3.5% · Net margin 2.8% · Return on equity 14.9% · Return on assets (EBIT) 10.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).
What moves the price
The share trades about 51% below its 52-week high and 31% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −1% fair-value upside, at 62%, LFVN screens cheaper than that median.
Fair Value models
Bear$6.13Fair Value $8.46Bull$10.58
Price $5.22 · Upside +62.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 4 months old). Earnings retained since then ($0.0814 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, one officer or director bought shares worth $12,134, on Sep 15, 2026. Over the same period, 2 people sold shares worth $141,149.
BuyDarwin LewisDirector5× since Dec 15, 2025: 7,496 shares, avg. $5.81$43,561Sep 15, 2026
SaleKristen CunninghamChief Sales Officer9,001 shares at $6.18$55,649Sep 14, 2026
SaleMichael A BeindorffDirector2× since Nov 19, 2025: 22,607 shares, avg. $7.36$166,437Jun 3, 2026
BuyJudd DaytonDirector33,197 shares at $4.59$152,422Mar 2, 2026
Plus 11 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−20.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.7%
Start year 2021 (pandemic). Over 10 years: −1.2% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+107.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+0.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−2.7%
Dividend (yield on the price)3.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−12.8% vs −0.4%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 3%
2026 sits 77% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.0%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
−0.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −4.3% a year for the price and −3.1% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (93 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
Compare Lifevantage Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 625 stocks
Beats the industry median on 10/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score67 · Top 25%
Fair Value upside+62.1% · Top 25%
Profitability
Return on equity (12 months)14.9% · Top 25%
Return on assets8.2% · Top 25%
Net margin (12 months)2.8% · Below median
Operating margin (12 months)3.9% · Below median
Growth and dividend
Revenue growth (quarter YoY)−23.1% · Bottom 25%
Dividend yield (12 months)3.5% · Above median
Balance sheet
Debt / equity0.10× · Above median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (12 months)12.7× · Cheaper than median
P/B1.97× · Pricier than median
P/S (12 months)0.36× · Cheapest 25%
Price / free cash flow (fiscal year)9.9× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Lifevantage Corporation Fair Value". https://www.fairvalue-calculator.com/stock/LFVN
Frequently asked questions
Is Lifevantage Corporation (LFVN) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of $8.46 versus a price of $5.22, about +62% upside (undervalued).
What is the fair value of LFVN?
Our model-based fair value for Lifevantage Corporation is $8.46 (as of Nov 8, 2026), built from audited fundamentals. The current price: $5.22.
What is the quality score of LFVN?
Lifevantage Corporation has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lifevantage Corporation (LFVN)?
Our model-based price target is the fair value of $8.46 (as of Nov 8, 2026) from 26 valuation models. Cautious scenario $6.13, optimistic scenario $10.58. It is a calculation from audited fundamentals, not an analyst target.
What is the Lifevantage Corporation stock forecast for 2026?
Our models put fair value at $8.46, about +62% upside versus a price of $5.22 (undervalued). Cautious scenario $6.13, optimistic scenario $10.58. The calculation is refreshed regularly with new filings.
What is the revenue of Lifevantage Corporation (LFVN)?
Lifevantage Corporation reported trailing-twelve-month revenue of about $183M (latest available figure, as of Nov 8, 2026).
Does Lifevantage Corporation pay a dividend?
Lifevantage Corporation currently shows a dividend yield of 3.54% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Lifevantage Corporation (LFVN) and when is the ex-dividend date?
Lifevantage Corporation pays a dividend of $0.185 per share a year, a dividend yield of 3.5%. The last ex-dividend date was Sep 1, 2026. A dividend has been paid every year since at least 2022. The payout ratio is 56.4% of earnings (on adjusted earnings, reported 45.1%). Free cash flow covers the dividend 2.86 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Lifevantage Corporation (LFVN)?
For today's price to be fair in a discounted-cash-flow model, Lifevantage Corporation would have to grow free cash flow by -2.0 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -3.7 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of LFVN use?
Our models discount Lifevantage Corporation at 11.8 %: a base by market capitalisation (micro), damped by beta 0.71, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Lifevantage Corporation that is -2.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Lifevantage Corporation (LFVN) delivered so far?
Over the past 5 years revenue at Lifevantage Corporation grew -3.7 % a year. The price currently implies free-cash-flow growth of -2.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Lifevantage Corporation (LFVN) growing?
The median revenue growth in the sector is +3.6 % a year. That is the yardstick for the growth priced into Lifevantage Corporation (-2.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Lifevantage Corporation (LFVN)?
The free-cash-flow yield on the price is 10.06 %: that much free cash flow Lifevantage Corporation produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Lifevantage Corporation (LFVN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lifevantage Corporation it is $8.46 per share (as of Nov 8, 2026), against a price of $5.22. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Lifevantage Corporation stock overvalued or undervalued in 2026?
As of Nov 8, 2026, LFVN trades below its calculated fair value: price $5.22, fair value $8.46, a gap of about +62% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LFVN?
No. The price is what the market pays today ($5.22); the fair value is what the company's own numbers justify ($8.46). For Lifevantage Corporation the two are $3.24 per share apart. That gap is exactly why we show both numbers side by side.
How much is Lifevantage Corporation worth?
The market values Lifevantage Corporation at about $66.2M (market capitalisation, as of Nov 8, 2026). Per share that is $5.22; our models calculate a fair value of $8.46 per share.
What do the bullish and bearish scenarios say about LFVN?
Our models span a range for Lifevantage Corporation: cautious scenario $6.13, base $8.46, optimistic $10.58 per share (as of Nov 8, 2026, price $5.22). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of LFVN?
Lifevantage Corporation trades at a price-to-earnings ratio of 12.7 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $8.46 is built from several models across several years. Excluding one-off items of fiscal year 2026 it is 16.3 (reported 12.7). Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings, FY2022 ex one-offs: 17.2. Other multiples: PEG 0.4, P/B 2.0, P/S 0.4, EV/EBITDA 5.8.
What is the PEG ratio of LFVN?
The PEG ratio of Lifevantage Corporation is 0.36 (P/E divided by earnings growth, as of Nov 8, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Lifevantage Corporation (LFVN)?
Balance-sheet figures for Lifevantage Corporation (as of Nov 8, 2026): return on equity 14.9%, debt of 0.10 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is LFVN from its 52-week high?
Lifevantage Corporation trades at $5.22, about 51% below its 52-week high of $10.70 and 31% above the low of $3.99 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $8.46 is for.
Which stocks are comparable to Lifevantage Corporation?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lifevantage Corporation stock attractive at the current price?
The data as of Nov 8, 2026: price $5.22, calculated fair value $8.46 (+62%), Quality Score 67/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LFVN calculated?
We run Lifevantage Corporation through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $8.46 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Lifevantage Corporation currently trades 38% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lifevantage Corporation (LFVN)?
The closing price on Nov 6, 2026 was $5.22. Our model-based fair value is $8.46, about +62% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lifevantage Corporation right now?
The price is below even our cautious bear case ($6.13). The market is more pessimistic than our downside scenario. Solid quality (67/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of Lifevantage Corporation (LFVN) come from?
Earnings per share at Lifevantage Corporation grew +3.4 % a year from 2015 to 2026. Broken into its drivers: revenue per share +1.4 %, EBIT margin −4.0 %, tax rate +2.0 %, residual (interest, one-offs) +4.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Lifevantage Corporation
How large is the market capitalisation of Lifevantage Corporation (LFVN)?
The market capitalisation of Lifevantage Corporation is $66.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lifevantage Corporation (LFVN)?
The price-to-sales ratio of Lifevantage Corporation is 0.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lifevantage Corporation (LFVN)?
Earnings per share at Lifevantage Corporation are $0.4100 (price ÷ EPS = P/E 12.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Lifevantage Corporation (LFVN)?
The dividend yield of Lifevantage Corporation is 3.5% (payout 56.4%, on adjusted earnings, reported 45.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Lifevantage Corporation (LFVN)?
The net margin of Lifevantage Corporation is 2.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lifevantage Corporation (LFVN)?
The return on equity (ROE) of Lifevantage Corporation is 14.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lifevantage Corporation (LFVN)?
On an EBIT basis the return on assets of Lifevantage Corporation is 10.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lifevantage Corporation (LFVN)?
The operating margin of Lifevantage Corporation is 3.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lifevantage Corporation (LFVN)?
Revenue at Lifevantage Corporation is growing −23.1% versus a year earlier (3y avg −5.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lifevantage Corporation (LFVN)?
Earnings per share at Lifevantage Corporation are growing −32.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Lifevantage Corporation (LFVN) hold?
Lifevantage Corporation holds more cash than debt, $5.1M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Lifevantage Corporation in the live analysis
One click puts Lifevantage Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026